Target intelligence / Profile preview

Ribosomal protein L37 pseudogene 21 (RPL37P21)

Target
RPL37P21
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L37 pseudogene 21 (RPL37P21) is a processed pseudogene related to the functional gene encoding ribosomal protein L37, a component of the large (60S) ribosomal subunit that participates in protein synthesis[2][13]. As a pseudogene, RPL37P21 does not encode a functional protein and is generally not expressed or studied as a therapeutic target. It is one of numerous ribosomal protein pseudogenes annotated in the human genome[10][13]. There is no evidence indicating that this pseudogene has a biological function, disease involvement, or pharmacological relevance. RPL37P21 is not a therapeutic target such as a receptor, enzyme, or transporter[13][10]. It lacks known biological functions and disease associations, in contrast to its parent gene (RPL37), which encodes an essential ribosomal protein[5][7][12]. No drugs, biomarker use, or safety concerns are linked to this pseudogene[2][13][11]. It is not incorrect as a gene symbol, but is not appropriate for therapeutic targeting purposes.

Other names
RPL37_11_1318RPL37P21

Beyond the preview

Go deeper on Ribosomal protein L37 pseudogene 21 (RPL37P21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L37 pseudogene 21 (RPL37P21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call